APOB and depressive symptom measurement: A pooled analysis of 230 metabolic markers in patients with depression revealed an atherogenic lipid profile in depression, marked by increased very low‐density lipoprotein, triglycerides, and ApoB alongside decreased high‐density lipoprotein (33).